P

Protagonist Therapeutics
D

PTGX

89.460
USD
2.11
(2.42%)
مفتوح الان
حجم التداول
30,168
الربح لكل سهم
-2
العائد الربحي
-
P/E
136
حجم السوق
5,591,401,167
أصول ذات صلة الأخبار المقالات
المزيد

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.